JPS5215829A - Medicine containing organosilicon compound as active agent - Google Patents

Medicine containing organosilicon compound as active agent

Info

Publication number
JPS5215829A
JPS5215829A JP51023340A JP2334076A JPS5215829A JP S5215829 A JPS5215829 A JP S5215829A JP 51023340 A JP51023340 A JP 51023340A JP 2334076 A JP2334076 A JP 2334076A JP S5215829 A JPS5215829 A JP S5215829A
Authority
JP
Japan
Prior art keywords
active agent
organosilicon compound
containing organosilicon
medicine containing
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51023340A
Other languages
Japanese (ja)
Inventor
Kirishiini Reimon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KORUSHIARU SOC
Cortial SA
Original Assignee
KORUSHIARU SOC
Cortial SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KORUSHIARU SOC, Cortial SA filed Critical KORUSHIARU SOC
Publication of JPS5215829A publication Critical patent/JPS5215829A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP51023340A 1975-04-21 1976-03-05 Medicine containing organosilicon compound as active agent Pending JPS5215829A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7513152A FR2308372A2 (en) 1975-04-21 1975-04-21 Medicaments for treatment of cardio-vascular troubles, atheroscleoris - hyperlipemia and hypercholesterolemia contain para-trimethylsilyl-phenoxy-isobutyric acid or para-trimethylsilyl-phenyl-alkanoic acids

Publications (1)

Publication Number Publication Date
JPS5215829A true JPS5215829A (en) 1977-02-05

Family

ID=9154530

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51023340A Pending JPS5215829A (en) 1975-04-21 1976-03-05 Medicine containing organosilicon compound as active agent

Country Status (2)

Country Link
JP (1) JPS5215829A (en)
FR (1) FR2308372A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020002121A (en) * 2018-05-07 2020-01-09 達興材料股▲ふん▼有限公司 Silicon-containing compound, and liquid-crystal composition and liquid-crystal display using the same

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454811A1 (en) * 1978-11-09 1980-11-21 Rocher Pierre APPARATUS FOR THE HEAT TREATMENT, IN PARTICULAR ASEPTISATION, OF CONTACT LENSES
EP1468693A3 (en) * 1993-12-10 2004-11-03 Merrell Pharmaceuticals Inc. Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL24062A (en) * 1965-07-29 1971-06-23 Broza M Silicon containing beta-phenylethylamines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020002121A (en) * 2018-05-07 2020-01-09 達興材料股▲ふん▼有限公司 Silicon-containing compound, and liquid-crystal composition and liquid-crystal display using the same

Also Published As

Publication number Publication date
FR2308372B2 (en) 1978-08-25
FR2308372A2 (en) 1976-11-19

Similar Documents

Publication Publication Date Title
JPS51131843A (en) Lipidddepleted active compound
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
GB1542848A (en) Anti-mycotic pharmaceutical compositions containing enzymes
ZA771003B (en) Pharmaceutical compositions containing pyrethrinoides
ZA764715B (en) Antiseptic compositions
JPS5253852A (en) Novel sterile compound
MW5076A1 (en) Pharmacologicalle active compounds
JPS52122323A (en) Platinum coordination compound* preparation thereof* medicine* for cancer* containing same as active constituent
JPS57163314A (en) Medicinal composition containing benzazepine derivative
ZA75381B (en) Heart active compounds
ZA765331B (en) Novel pharmaceutically active compounds
GB1549171A (en) Pharmaceutical formulations containing hydrocy bezophenonederivatives
GB1548837A (en) Compositions containing medicament for topical application
IL48997A0 (en) Therapeutic compositions containing xylitol
ZA754240B (en) Heart active compounds
JPS5215826A (en) Medical composition
GB1538326A (en) Organosilicon compounds
NZ182751A (en) Fungicidal compositions containing natamycin
JPS5215829A (en) Medicine containing organosilicon compound as active agent
JPS5566510A (en) Medical composition containing aryltrifluoroethanol compound
ZA76150B (en) Pharmaceutical ferrocene compound
IL52103A0 (en) Pharmaceutical compositions containing naphthopyrane derivvatives
JPS5282709A (en) Preparation of insulinnlike active substance
JPS5238034A (en) Medicine containing organosilion compound as active agent
JPS5259624A (en) Compound capsulated